Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
5.59
-0.14 (-2.44%)
At close: Oct 6, 2025, 4:00 PM EDT
5.51
-0.08 (-1.43%)
Pre-market: Oct 7, 2025, 4:58 AM EDT
Vir Biotechnology Market Cap
Vir Biotechnology has a market cap or net worth of $776.54 million as of October 7, 2025. Its market cap has decreased by -27.14% in one year.
Market Cap
776.54M
Enterprise Value
272.75M
1-Year Change
-27.14%
Ranking
Category
Stock Price
$5.59
Market Cap Chart
Since October 11, 2019, Vir Biotechnology's market cap has decreased from $1.53B to $776.54M, a decrease of -49.37%. That is a compound annual growth rate of -10.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 795.99M | -21.26% |
| Dec 31, 2024 | 1.01B | -25.30% |
| Dec 29, 2023 | 1.35B | -59.83% |
| Dec 30, 2022 | 3.37B | -38.52% |
| Dec 31, 2021 | 5.48B | 60.63% |
| Dec 31, 2020 | 3.41B | 147.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |